Immunome
Immunome is a pharmaceutical company that develops novel drugs for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed Immunome Information
Geographic Data
Address: 665 Stockton Drive
City: Exton
State: PA
Zip: 19341
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$125M
Raised Total:$83M
Social
Metrics
7,343,591Website Global Rank
608Website Monthly Traffic
Twitter Followers
Description
Immunome is a pharmaceutical company that develops novel drugs for the treatment of cancer.
Contact Phone:
+16103213700
Contact Email:
Immunome went public on 10/1/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/1/2020
IPO Valuation:
$120M
Ticker Symbol:
IMNM
IPO Price:
$12/share
Amount Raised:
$39M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2021 | Post-IPO Equity | $27M | 12/2019 | Series A | 1 | $180k |
Robin Hood Ventures Robin Hood Ventures |
1/2012 | Seed Round | 1 | $145k |
BioAdvance BioAdvance |
10/2016 | Series A | 2 | $7.2M |
BioAdvance Evolution VC Partners BioAdvance Evolution VC Partners |
11/2019 | Venture Round | $9.3M | 2/2019 | Debt | $6.5M | 10/2020 | IPO | $39M |
|
6/2020 | Venture Round | 1 | $11M |
Robin Hood Ventures Robin Hood Ventures Robin Hood Ventures Robin Hood Ventures |
11/2013 | Venture Round | 1 | - |
BioAdvance BioAdvance |
4/2020 | Debt | $350k |
U.S. Small Business Administration. |
5/2017 | Equity | $5M | 7/2016 | Series A | $5M | 5/2017 | Series A | - | 9/2009 | Seed Round | 1 | $435.4k |
BioAdvance BioAdvance |
2/2013 | Venture Round | 1 | $445k |
BioAdvance BioAdvance |
10/2014 | Venture Round | 1 | $467.5k |
BioAdvance BioAdvance |
6/2011 | Venture Round | 1 | $846.6k |
BioAdvance BioAdvance |
9/2010 | Venture Round | 1 | - |
BioAdvance BioAdvance |
2/2015 | Debt Financing | 1 | $200k |
Robin Hood Ventures Robin Hood Ventures |
3/2014 | Debt Financing | $735k | 6/2023 | Post-IPO Equity | $125M | 7/2021 | Grant | 1 | $17.6M |
JPEO-CBRND JPEO-CBRND JPEO-CBRND JPEO-CBRND |
7/2020 | Post-IPO Equity | 1 | $13.3M |
U.S. Department of Defense U.S. Department of Defense U.S. Department of Defense U.S. Department of Defense |
5/2017 | Series A | - |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 6/2023 | MorphImmune |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
